* Apollo Medical Holdings Inc AMEH.OQ AMEH.O is expected
to show a fall in quarterly revenue when it reports results on
February 24.
* The Alhambra California-based company is expected to
report a
1.4% decrease in revenue to $174.25 million from $176.78 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Apollo Medical
Holdings
Inc is for earnings of 27 cents per share. For the same quarter
last year, the company reported earnings of 27 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Apollo
Medical
Holdings Inc is $92, about 40.9% above its last closing price
of $54.37.
This summary was machine generated February 22 at 21:10 GMT.
All figures in US dollars unless otherwise stated